Cochlear | COH - Przychody Ze Sprzedaży

Cena Akcji
172.10
Dzienna Zmiana
-1.34 -0.77%
Miesięcznie
-6.17%
Rocznie
-31.32%
Q2 Prognozy TE
168.61




Obroty Zmiana Data
Ansell USD 1.03B 192.2M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Fisher Paykel Healthcare NZD 1.1B 21.3M 2025-12
Healius AUD 688.1M 245.8M 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Mayne Pharma AUD 212.07M 17.03M 2025-12
Mesoblast USD 30.3M 17.1M 2025-12
Monash IVF AUD 137.86M 72.09M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
Regis Healthcare AUD 667.75M 70.63M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Somnomed AUD 45.11M 1.46M 2023-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12